Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths
Thursday, December 11 2008 03:27
Other adverse effects remain, requiring careful balancing of benefits with risks
Treating prostate cancer patients with drugs that block male hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. But the treatment does increase risks of diabetes and heart disease. How can this outcome hold true?
Read more: Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths
Selenium Blood Levels and Prostate Cancer Risk, European Results
Last Updated (Thursday, December 18 2008 12:13) Monday, December 08 2008 07:10
Selenium is widely sold to men who takein supplement form witht he aim of preventing prostate cancer. Now evidence from a large study suggests that selenium does not offer the protection hoped for.
Read more: Selenium Blood Levels and Prostate Cancer Risk, European Results
Suppressing GRP78 Halts Prostate Cancer Development
Tuesday, November 25 2008 00:00
Inactivating a specific biomarker for aggressive prostate cancer, called GRP78, blocks the development of prostate cancer in animal models according to researchers at the University of Southern California (USC). This breakthrough discovery may lead to a novel cancer therapy for humans.
Read more: Suppressing GRP78 Halts Prostate Cancer Development
Prostate Tumors Grow New Nerves
Monday, December 01 2008 17:38
Prostate cancer – and perhaps other cancers – promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Previous research showed that prostate cancer follows the growth of nerves, but this is the first time that scientists have demonstrated that the tumors actually promote nerve growth.
Minority Patients Prefer Empowering Cancer Messages
Equal Cancer Care - African American
Thursday, October 30 2008 00:00
Harping on negative consequences of a lack of cancer screening among minorities can actually make African-Americans less likely to go for screening, according to behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Read more: Minority Patients Prefer Empowering Cancer Messages
More Articles...
Page 7 of 8
